Peptide manufacturers in India: what can be verified?
There is no defensible public-data basis for the previous numbered “top 10” ranking. The companies below publish different kinds of peptide capability, so this page compares only what their own current materials describe. A capability statement is not an independent assessment of quality, a confirmation that a particular molecule is available, or proof that every site or product has the same status.
Published peptide capabilities at a glance
| Company and India site | What its public materials describe | Useful distinction |
|---|---|---|
| Piramal Pharma Solutions, Turbhe | Peptide API development and commercial manufacturing using solution-phase and solid-phase synthesis; the company describes downstream processing and a generic peptide API portfolio. | The site page explicitly describes peptide API development and manufacturing at Turbhe. |
| Auro Peptides | The company describes synthetic peptide API development and manufacturing, from milligram to kilogram scale, and publishes a peptide product list. Aurobindo separately disclosed a US FDA inspection of the Auro Peptides synthetic peptide API facility in February 2024, completed with zero observations. | The inspection statement is tied to the named facility and date; it does not establish a blanket approval for every product, site, or future inspection. |
| Divi’s Laboratories | Its custom-synthesis page describes peptide fragments up to 14 amino-acid residues and peptide building-block synthesis. | The published page describes fragments and building blocks, not a universal offer to manufacture every finished peptide API. |
| Anthem Biosciences | Its infrastructure page lists newly commissioned commercial peptide and high-potency manufacturing facilities. | The public page identifies a facility capability but does not provide the same product-level scope as the other entries. |
How these company capabilities differ
“Peptide manufacturer” can describe distinct services: custom synthesis for a research program, peptide fragments or building blocks, development of a peptide API process, or commercial API supply. The four company pages above do not describe an interchangeable service set. Compare a specific project with each company’s published scope and ask whether the named site handles the molecule, stage, scale, and service you need.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Why this is not a top-10 ranking
The prior page assigned objective scores and ranked ten companies without publishing a reproducible dataset or a consistent comparison of the same service. Its unsupported claims about industry-wide regulatory counts, manufacturing capacity, analytical packages, prices, and company-specific expansion have been removed. This page does not infer a company’s ranking, product availability, or regulatory standing from company size or a general corporate statement.
Company and primary sources
- Piramal Pharma Solutions: Turbhe peptide API development and manufacturing.
- Auro Peptides: business unit and published peptide capabilities.
- Aurobindo Pharma: February 16, 2024 disclosure about the completed US FDA inspection at Auro Peptides’ synthetic peptide API facility.
- Divi’s Laboratories: custom synthesis and peptide fragments.
- Anthem Biosciences: infrastructure and peptide manufacturing.
Related peptide guides
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →